3,704 SPDR S&P Biotech ETF $XBI Shares Acquired by Pekin Hardy Strauss Inc.

Pekin Hardy Strauss Inc. lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 52.2% during the third quarter, HoldingsChannel reports. The fund owned 10,804 shares of the exchange traded fund’s stock after purchasing an additional 3,704 shares during the quarter. Pekin Hardy Strauss Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,704,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of XBI. Wellington Management Group LLP acquired a new position in SPDR S&P Biotech ETF in the 2nd quarter worth about $19,270,000. Ayalon Insurance Comp Ltd. raised its stake in shares of SPDR S&P Biotech ETF by 71.9% during the 3rd quarter. Ayalon Insurance Comp Ltd. now owns 95,600 shares of the exchange traded fund’s stock worth $15,074,000 after purchasing an additional 40,000 shares in the last quarter. TD Waterhouse Canada Inc. raised its stake in shares of SPDR S&P Biotech ETF by 535.1% during the 2nd quarter. TD Waterhouse Canada Inc. now owns 5,265 shares of the exchange traded fund’s stock worth $824,000 after purchasing an additional 4,436 shares in the last quarter. Maven Securities LTD purchased a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth about $3,028,000. Finally, Syon Capital LLC raised its stake in shares of SPDR S&P Biotech ETF by 67.9% during the 2nd quarter. Syon Capital LLC now owns 23,562 shares of the exchange traded fund’s stock worth $3,729,000 after purchasing an additional 9,530 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock traded up $3.81 during trading on Friday, hitting $152.21. 10,549,785 shares of the stock traded hands, compared to its average volume of 9,198,628. The stock has a market cap of $10.41 billion, a P/E ratio of 11.47 and a beta of 0.87. SPDR S&P Biotech ETF has a twelve month low of $106.30 and a twelve month high of $169.89. The company has a fifty day moving average price of $155.22 and a two-hundred day moving average price of $142.29.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.